Lenacapavir and cabotegravir PrEP supported for use in pregnancy and breastfeeding
Intermittent HIV treatment dosing may be a response to the funding crisis, but adolescent study raises concerns
PEPFAR study shows the deadly impact of stopping children’s HIV treatment
Children in Kenya and Uganda experiencing stock-outs of crucial HIV medicines like dolutegravir
Mothers living with HIV feel like there is no right choice when feeding their babies
Six years after pregnancy, almost half of women with HIV in Tanzania have dropped out of care
Adequate levels of folate protect against neural tube defects when taking dolutegravir
Young adults with HIV have high prevalence of heart disease risk factors
Adolescent mothers with HIV in South Africa have poorer HIV outcomes than non-mothers, study finds
